REMUS latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Sep 2026, promoters held 70.95% of Remus Pharmaceuticals Ltd, FIIs 5.1%, DIIs 0.43%, government - and the public 23.52%, across 2,092 shareholders.